ANI Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ANI Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 54% to $486,816,000. The net income raised on $18,779,000 and profit margin reached 4%. Total operating expenses were $258,332,000.
Profit Margin
| 2014 | 55.97M | 28.74M | 51.36% |
|---|---|---|---|
| 2015 | 76.32M | 15.37M | 20.14% |
| 2016 | 128.62M | 3.93M | 3.06% |
| 2017 | 176.84M | -1.07M | -0.61% |
| 2018 | 201.57M | 15.49M | 7.69% |
| 2019 | 206.54M | 6.09M | 2.95% |
| 2020 | 208.47M | -22.54M | -10.82% |
| 2021 | 216.13M | -42.60M | -19.71% |
| 2022 | 316.38M | -47.89M | -15.14% |
| 2023 | 486.81M | 18.77M | 3.86% |
ANIP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 486.81M | 316.38M | 216.13M | 208.47M | 206.54M | 201.57M | 176.84M | 128.62M | 76.32M | 55.97M |
Cost of revenue | 181.51M | 138.78M | 100.61M | 87.15M | 63.15M | 73.02M | 79.03M | 48.78M | 12.69M | 11.47M |
Gross profit | 305.30M | 177.6M | 115.52M | 121.31M | 143.39M | 128.55M | 97.81M | 79.84M | 63.63M | 44.49M |
Operating exp. | ||||||||||
Research and development | 34.28M | 22.31M | 11.36M | 16.00M | 19.80M | 15.38M | 9.07M | 2.90M | 2.87M | 2.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 258.33M | 203.33M | 143.69M | 136.88M | 126.96M | 93.19M | 68.57M | 53.07M | 30.93M | 24.49M |
Operating income | 46.97M | -25.06M | -32.51M | -16.06M | 16.35M | 35.35M | 28.32M | 20.07M | 32.7M | 20.00M |
Other income (expenses), net | -27.09M | -37.60M | -23.54M | -9.94M | -13.19M | -550K | -11.98M | -6.75M | -10.96M | -627K |
Income before tax | 19.87M | -62.66M | -56.05M | -25.96M | 3.15M | 20.05M | 16.34M | 8.67M | 21.73M | 19.37M |
Income tax expense | 1.09M | -14.76M | -13.45M | -3.41M | -2.93M | 4.55M | 17.42M | 4.74M | 6.35M | -9.36M |
Net income | 18.77M | -47.89M | -42.60M | -22.54M | 6.09M | 15.49M | -1.07M | 3.93M | 15.37M | 28.74M |
Earnings per share | ||||||||||
Basic EPS | 0.95 | -2.95 | -3.38 | -1.88 | 0.51 | 1.33 | -0.09 | 0.34 | 1.34 | 2.61 |
Diluted EPS | 0.94 | -2.95 | -3.38 | -1.88 | 0.5 | 1.32 | -0.09 | 0.34 | 1.32 | 2.59 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |